Comparison of amlodipme and long-acting diltiazem in the treatment of mild or moderate hypertension

American Journal of Hypertension

Volumn 10, Issue 11, 1997, Pages 1263-1269

  Horwitz, Lawrence D ^a   Weinberger, Howard D ^a   Clegg, Lois ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Ambulatory blood pressure; Amlodipine; Calcium channel antagonists; Diltiazem

Indexed keywords

AMLODIPINE; DILTIAZEM; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERANCE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BLOOD PRESSURE; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT; PATIENT COMPLIANCE;

ADULT; AGED; AGED, 80 AND OVER; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DILTIAZEM; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT DROPOUTS;

EID: 0031260630     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00264-1     Document Type: Article

References (17)

1. Giles TD: Monotherapy with calcium antagonists for mind to moderate primary hypertension. Cardiovasc Drug Rev 1990;8:138-154.
2. 2. Van Zwieten PA, Pfaffendorf M: Similarities and differences between calcium antagonists: pharmacological aspects. J Hypertens 1993;11(suppl 1):S3-S11.
3. 3. Psaty BM, Heckbert SR, Koepsell TD, et al: The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
4. 4. Furberg CD, Psaty BM, Meyer JV: Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
5. 5. Burges RA, Dodd MG, Gardiner DG: Pharmacologic profile of amlodipine. Am J Cardiol 1989;64:101-201.
6. 6. Massie BM, Der E, Herman TS, Topolski P: 24-hour efficacy of once daily diltiazem in essential hypertension. Clinical Cardiology 1992;15:365-368.
7. 7. Frishman WH, Brobyn R, Brown RD, et al: Amlodipine versus atenolol in essential hypertension. Am J Cardiol 1994;73:50a-54a.
8. 8. Mehta JL, Lopez LM, Vlachakis ND, et al: Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension. Am Heart J 1993;125:1704-1710.
9. 9. Felicetta JV, Serfer HM, Cutler NR, et al: A dose-response trial of once-daily diltiazem. Am Heart J 1992;123:1022-1026.
10. 10. Weir MR: Diltiazem: ten years of clinical experience in the treatment of hypertension. J Clin Pharmacol 1995; 35:220-232.
11. 11. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213:1143-1152.
12. 12. The Australian Therapeutic Trial in Mild Hypertension: Report by the management committee. Lancet 1980;i:1261-1267.
13. 13. Casale PN, Devereux RB, Milner M, et al: Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986;105:173-178.
14. 14. Weir RJ, Lee PS, Clegg DS, et al: A multicentre study to compare the therapeutic efficacy of sustained-release diltiazem and enalapril in the treatment of patients with mild to moderate hypertension. Br J Clin Pract 1994;48:287-292.
15. 15. Leppert J, Nilsson H, Myrdal U, et al: Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls. Cardiovasc Drugs Therapy 1993;7:901-907.
16. 16. Siscovick DS, Raghunathan TE, Psaty BM, et al: Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-1857.
17. 17. Hoes AW, Grobbee DE, Lubsen J, et al: Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Annals Intern Med 1995;123:481-487.